Tianfeng TF-SFD-5E Pharmaceutical-Grade Shelf-Type Freeze Dryer

Overview

The Tianfeng TF-SFD-5E is a pharmaceutical-grade, shelf-type freeze dryer engineered for pilot-scale development and small-batch production of thermolabile biopharmaceuticals, traditional Chinese medicinal herbs, sterile injectables, and biological specimens. It operates on the fundamental principle of lyophilization—sequential freezing, primary drying (sublimation under high vacuum), and secondary drying (desorption)—to remove water while preserving structural integrity, bioactivity, and chemical stability. Unlike conventional thermal drying methods, this system maintains product morphology, porosity, reconstitution kinetics, and residual moisture content below 2% w/w—critical parameters for regulatory compliance in GMP environments. Designed for compatibility with stainless-steel chambers and electropolished shelves, the TF-SFD-5E meets the mechanical and thermal demands of process validation studies, cycle development, and batch documentation required by pharmacopoeial standards including USP , EP 2.9.40, and ChP 0931.

Key Features

• Robust stainless-steel chamber and condenser housing with full-welded construction and ISO-KF vacuum port interfaces
• Six temperature-controlled shelves (five active + one bottom shelf) with independent PID regulation across −55 °C to +70 °C, enabling precise control of freezing ramp rates, annealing, and desorption profiles
• High-efficiency dual-stage cascade refrigeration system achieving stable −75 °C condenser temperature, optimized for low-vapor-pressure solvents and high-moisture-load formulations
• Ultimate vacuum capability of ≤2.7 Pa, maintained via oil-free dry vacuum pump or optional hybrid pump configuration to minimize hydrocarbon contamination risk
• Integrated pressure rise test (PRT) functionality and real-time leak rate monitoring (≤0.1 Pa·m³/s), supporting routine verification per ASTM F2476 and ISO 13408-1
• Modular electrical architecture with 43 kW total installed power, including 10 kW shelf heating capacity for controlled secondary drying without thermal overshoot
• Full-spectrum data logging compliant with FDA 21 CFR Part 11 requirements, featuring electronic signatures, audit trails, and user-level access control

Sample Compatibility & Compliance

The TF-SFD-5E accommodates diverse sample formats: bulk solutions up to 105 L, vials (Φ16 mm: 24,800 units; Φ22 mm: 12,700 units), ampoules, serum bottles, and irregularly shaped botanical matrices such as sliced ginseng, cordyceps, and notoginseng roots. Its validated performance supports lyophilization of monoclonal antibodies, live-attenuated vaccines, enzyme preparations, plasma derivatives, and herbal extracts containing heat-labile saponins, polysaccharides, and volatile oils. All wetted surfaces comply with ASME BPE-2021 surface finish specifications (Ra ≤ 0.6 µm). The system is manufactured under an ISO 9001:2000–certified quality management system, with documented design history files (DHF), risk assessments (FMEA), and IQ/OQ protocols available upon request. It satisfies baseline requirements for GLP-compliant stability studies and GMP-aligned process validation per ICH Q5C and Q8(R2).

Software & Data Management

Equipped with Tianfeng’s proprietary LyoControl™ v4.2 software, the TF-SFD-5E provides full-cycle automation with customizable ramp/soak profiles, real-time graphing of shelf temperature, chamber pressure, condenser temperature, and product thermocouple signals. Data is stored in encrypted SQLite databases with automatic daily backup to network drives or NAS devices. Audit trail records capture all operator actions, parameter changes, alarm events, and calibration interventions—including timestamps, user IDs, and reason-for-change entries. Export options include CSV, PDF, and XML formats compatible with LIMS integration. Remote monitoring via secure HTTPS interface allows off-site supervision without compromising data integrity or cybersecurity posture.

Applications

• Pre-formulation studies and cycle optimization for parenteral biologics (e.g., lyophilized mAbs, fusion proteins)
• Stabilization of TCM extracts—preserving glycosidic bonds, terpenoid integrity, and antioxidant capacity in Panax ginseng, Cordyceps sinensis, and Notoginseng radix
• Production of sterile powder-in-vial formulations for oncology, immunology, and anti-infective therapeutics
• Long-term cryopreservation of cell lines, tissue grafts, and diagnostic reagents requiring structural fidelity post-reconstitution
• Process development for veterinary vaccines, probiotic powders, and nutraceutical actives sensitive to Maillard reactions or oxidative degradation
• Academic research in biomaterial scaffold fabrication, porous ceramic synthesis, and aerogel templating via freeze-casting

FAQ

What is the maximum allowable residual moisture for pharmaceutical lyophilizates processed on the TF-SFD-5E?
Residual moisture levels are determined by process parameters—not equipment limits—but typical target ranges fall between 0.5–2.0% w/w for protein-based products and 3–5% w/w for botanical matrices, verified via Karl Fischer titration.
Does the system support steam-in-place (SIP) or clean-in-place (CIP) functionality?
No—this model is designed for non-sterile barrier applications and manual cleaning per SOPs; SIP/CIP integration requires custom engineering and is not part of the standard TF-SFD-5E configuration.
Can the TF-SFD-5E be qualified for use in a regulated GMP manufacturing suite?
Yes—when supplied with full qualification documentation (DQ/IQ/OQ/PQ), calibrated sensors traceable to NIST standards, and validated software, it meets baseline requirements for Annex 1 and EU GMP Chapter 3 environments.
Is remote service access enabled by default?
Remote diagnostics and firmware updates require prior customer authorization and deployment of a dedicated industrial firewall; no outbound connections are initiated without explicit consent.
What materials are used for shelf construction?
Shelves are fabricated from 316L stainless steel with electrochemical passivation and Ra ≤ 0.6 µm surface finish, conforming to USP extractables testing protocols.